Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0294 | 0.2713 | 0.0726 |
Loa Loa (eye worm) | hypothetical protein | 0.0715 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0294 | 0.2713 | 0.2713 |
Echinococcus multilocularis | small conductance calcium activated potassium | 0.0405 | 0.4632 | 0.2633 |
Loa Loa (eye worm) | hypothetical protein | 0.0405 | 0.4632 | 0.4632 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0715 | 1 | 0.5 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0715 | 1 | 0.5 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0335 | 0.3424 | 1 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.0715 | 1 | 1 |
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.0335 | 0.3424 | 0.5 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.0715 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0405 | 0.4632 | 0.3169 |
Schistosoma mansoni | patched 1 | 0.0294 | 0.2713 | 0.0726 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.0715 | 1 | 0.5 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.0715 | 1 | 1 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0294 | 0.2713 | 0.2713 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0335 | 0.3424 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0405 | 0.4632 | 0.3169 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0715 | 1 | 0.5 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0335 | 0.3424 | 1 |
Echinococcus granulosus | small conductance calcium activated potassium | 0.0405 | 0.4632 | 0.2633 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0715 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.